← All trials
NCT03277690
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 26, 2017
- Primary completion
- May 30, 2019
- Completion date
- Jul 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cortendo ABLead sponsor
- Cortendo ABStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.